Can very high triglycerides cause pancreatitis?

Yes, very high triglycerides (above 500 mg/dL) can cause acute pancreatitis, a serious inflammatory condition. Regular monitoring and lifestyle changes can help prevent this dangerous complication.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

The connection between extremely high triglycerides and pancreatitis is one of the most serious complications of severe hypertriglyceridemia. While many people know that high triglycerides increase heart disease risk, fewer realize that when triglyceride levels soar above 500 mg/dL, they can trigger acute pancreatitis—a painful and potentially life-threatening condition that requires immediate medical attention.

Understanding this relationship is crucial for anyone with elevated triglycerides, as early intervention can prevent this dangerous complication. Let's explore how triglycerides cause pancreatitis, what levels pose the greatest risk, and most importantly, how you can protect yourself through monitoring and lifestyle changes.

The Triglyceride-Pancreatitis Connection

Triglycerides are a type of fat found in your blood that your body uses for energy. When triglyceride levels become extremely elevated—typically above 500 mg/dL and especially above 1,000 mg/dL—they can directly cause acute pancreatitis. This occurs through several mechanisms that overwhelm the pancreas's normal function.

Triglyceride Levels and Pancreatitis Risk

Triglyceride Level (mg/dL)Risk CategoryPancreatitis RiskAction Required
Less than 150<150 mg/dLNormalMinimalRoutine monitoring
150-199150-199 mg/dLBorderline HighVery LowLifestyle modifications
200-499200-499 mg/dLHighLowAggressive lifestyle changes, possible medication
500-999500-999 mg/dLVery HighModerate to HighImmediate medical intervention required
1000+≥1000 mg/dLExtremely HighVery HighEmergency medical care, hospitalization may be needed

Risk levels are based on fasting triglyceride measurements and may vary based on individual factors and underlying conditions.

How High Triglycerides Damage the Pancreas

When triglyceride levels are severely elevated, pancreatic lipase enzymes break down these fats into free fatty acids within the pancreatic capillaries. These free fatty acids are toxic to pancreatic cells and cause direct cellular damage. Additionally, the high concentration of triglyceride-rich lipoproteins can increase blood viscosity, reducing blood flow to the pancreas and creating areas of ischemia (oxygen deprivation).

The inflammatory cascade that follows leads to pancreatic cell death, enzyme release, and the characteristic symptoms of acute pancreatitis. This process can happen rapidly, which is why triglyceride-induced pancreatitis often presents as a medical emergency.

Risk Levels and Statistics

Research shows that hypertriglyceridemia accounts for approximately 1-14% of all acute pancreatitis cases, making it the third most common cause after gallstones and alcohol. The risk increases dramatically with triglyceride levels. Understanding these risk thresholds is essential for prevention.

Recognizing the Warning Signs

Acute pancreatitis caused by high triglycerides presents with classic symptoms that require immediate medical attention. The condition typically develops rapidly, often within hours of a triggering event such as a high-fat meal or alcohol consumption.

Primary Symptoms

  • Severe abdominal pain that radiates to the back
  • Nausea and vomiting that doesn't improve
  • Fever and chills
  • Rapid pulse and breathing
  • Abdominal tenderness and swelling
  • Oily or fatty stools (steatorrhea)

The abdominal pain is typically described as constant, boring, and severe—often rated 8-10 out of 10 on pain scales. Unlike other types of abdominal pain, it doesn't improve with position changes and may worsen when lying flat.

When to Seek Emergency Care

If you have known high triglycerides and experience severe abdominal pain with nausea and vomiting, seek emergency medical care immediately. Triglyceride-induced pancreatitis can progress rapidly to severe complications including pancreatic necrosis, organ failure, and death if not treated promptly.

Who's at Greatest Risk?

While anyone can develop high triglycerides, certain factors significantly increase the risk of reaching dangerous levels that could trigger pancreatitis. Understanding these risk factors helps identify who needs more aggressive monitoring and intervention.

Genetic and Medical Conditions

Several genetic disorders can cause severe hypertriglyceridemia, including familial hypertriglyceridemia, lipoprotein lipase deficiency, and apolipoprotein C-II deficiency. People with these conditions often have triglyceride levels above 1,000 mg/dL from childhood and require specialized medical management.

Medical conditions that increase pancreatitis risk include diabetes (especially poorly controlled), hypothyroidism, kidney disease, and metabolic syndrome. These conditions can independently raise triglyceride levels and, when combined with other risk factors, create a perfect storm for dangerous elevations.

Lifestyle and Medication Factors

  • Excessive alcohol consumption
  • High-carbohydrate, high-sugar diets
  • Obesity, particularly abdominal obesity
  • Physical inactivity
  • Certain medications (beta-blockers, diuretics, estrogen, steroids)
  • Pregnancy (especially third trimester)

Regular monitoring of triglyceride levels is essential for anyone with these risk factors, as early detection allows for intervention before levels reach dangerous thresholds.

Treatment and Management Strategies

Managing triglyceride levels to prevent pancreatitis requires a multi-faceted approach that addresses both immediate risk reduction and long-term prevention. The treatment strategy depends on the severity of elevation and underlying causes.

Immediate Medical Intervention

When triglycerides exceed 1,000 mg/dL, immediate medical intervention is often necessary. Treatment may include plasmapheresis (blood filtering to remove triglycerides), insulin therapy to enhance triglyceride clearance, and strict dietary fat restriction. Hospitalization is frequently required to monitor for pancreatitis development and manage complications.

Medication Options

Several medications can effectively lower triglycerides when lifestyle changes aren't sufficient. Fibrates (like fenofibrate) are often first-line therapy for severe hypertriglyceridemia. High-dose omega-3 fatty acids (prescription formulations) can reduce triglycerides by 20-50%. Niacin and statins may also be used, depending on the individual's lipid profile and cardiovascular risk.

Prevention Through Lifestyle Changes

The most effective way to prevent triglyceride-induced pancreatitis is maintaining healthy triglyceride levels through consistent lifestyle modifications. These changes can dramatically reduce triglyceride levels and eliminate pancreatitis risk for many people.

Dietary Modifications

Diet plays the most significant role in triglyceride management. Reducing refined carbohydrates and added sugars can lower triglycerides by 20-30% within weeks. Focus on complex carbohydrates, lean proteins, and healthy fats while limiting alcohol consumption, which can cause dramatic triglyceride spikes in susceptible individuals.

  • Limit refined sugars and high-fructose corn syrup
  • Choose complex carbohydrates over simple carbs
  • Include omega-3 rich fish 2-3 times per week
  • Reduce saturated and trans fats
  • Control portion sizes to maintain healthy weight
  • Limit alcohol consumption significantly

Exercise and Weight Management

Regular physical activity can reduce triglycerides by 20-30% independent of weight loss. Both aerobic exercise and resistance training are beneficial, with the greatest improvements seen in people who combine both types of activity. Even modest weight loss of 5-10% can significantly improve triglyceride levels.

Monitoring and Testing Guidelines

Regular monitoring is essential for anyone at risk of severe hypertriglyceridemia. The frequency of testing depends on your baseline levels, risk factors, and response to treatment.

Testing Frequency Recommendations

People with triglycerides above 200 mg/dL should be tested every 3-6 months until levels stabilize in a healthy range. Those with levels above 500 mg/dL may need monthly monitoring initially, especially when starting new treatments. Understanding your triglyceride trends helps predict and prevent dangerous spikes.

Additional Biomarkers to Monitor

Beyond triglycerides, monitoring related biomarkers provides a complete picture of your metabolic health. These include fasting glucose and HbA1c (diabetes risk), liver enzymes (medication monitoring), and inflammatory markers like high-sensitivity CRP. A comprehensive metabolic panel helps identify underlying conditions contributing to high triglycerides.

Long-term Outlook and Prevention

With proper management, most people can maintain triglyceride levels well below the pancreatitis risk threshold. The key is consistent monitoring, lifestyle adherence, and working closely with healthcare providers to adjust treatment as needed.

People who have experienced triglyceride-induced pancreatitis have an increased risk of recurrence if triglycerides aren't well-controlled. However, with aggressive management, many can prevent future episodes and maintain good quality of life. The prognosis is excellent for those who commit to long-term lifestyle changes and appropriate medical therapy.

Remember that preventing triglyceride-induced pancreatitis is entirely achievable through proactive management. Regular testing, lifestyle modifications, and appropriate medical treatment when needed can keep you safe from this serious complication while improving your overall metabolic health.

References

  1. Scherer, J., Singh, V. P., Pitchumoni, C. S., & Yadav, D. (2014). Issues in hypertriglyceridemic pancreatitis: an update. Journal of Clinical Gastroenterology, 48(3), 195-203.[PubMed][DOI]
  2. Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. (2012). Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis. Best Practice & Research Clinical Endocrinology & Metabolism, 28(3), 423-437.[PubMed][DOI]
  3. Valdivielso, P., Ramírez-Bueno, A., & Ewald, N. (2014). Current knowledge of hypertriglyceridemic pancreatitis. European Journal of Internal Medicine, 25(8), 689-694.[PubMed][DOI]
  4. Nawaz, H., Koutroumpakis, E., Easler, J., Slivka, A., Whitcomb, D. C., Singh, V. P., ... & Yadav, D. (2015). Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis. American Journal of Gastroenterology, 110(10), 1497-1503.[PubMed][DOI]
  5. Ewald, N., Hardt, P. D., & Kloer, H. U. (2009). Severe hypertriglyceridemia and pancreatitis: presentation and management. Current Opinion in Lipidology, 20(6), 497-504.[PubMed][DOI]
  6. Zheng, Y., Zhou, Z., Li, H., Li, J., Li, A., Ma, B., ... & Li, J. (2017). A multicenter study on etiology of acute pancreatitis in Beijing during 5 years. Pancreas, 46(7), 895-900.[PubMed][DOI]

Frequently Asked Questions

How can I test my triglycerides at home?

You can test your triglycerides at home with SiPhox Health's Heart & Metabolic Program. This CLIA-certified program includes triglyceride testing along with other cardiovascular and metabolic biomarkers, providing lab-quality results from the comfort of your home with regular monitoring to track your levels over time.

What triglyceride level causes pancreatitis?

Pancreatitis risk begins when triglycerides exceed 500 mg/dL, with the highest risk occurring above 1,000 mg/dL. However, some cases have been reported with levels as low as 400 mg/dL, especially in people with other risk factors.

How quickly can high triglycerides cause pancreatitis?

Triglyceride-induced pancreatitis can develop rapidly, often within hours of a triggering event like a high-fat meal or alcohol consumption. This is why people with very high triglycerides need immediate medical attention and aggressive treatment.

Can you prevent pancreatitis if you have high triglycerides?

Yes, pancreatitis is preventable by maintaining triglyceride levels below 500 mg/dL through diet, exercise, weight management, and medication when necessary. Regular monitoring and lifestyle changes are highly effective at preventing this serious complication.

What should I do if I have triglycerides over 500 mg/dL?

Triglycerides over 500 mg/dL require immediate medical attention. Contact your healthcare provider right away for evaluation and treatment, which may include medications, dietary restrictions, and close monitoring to prevent pancreatitis.

Related Articles

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details